Finance News World

Irritable Bowel Syndrome Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working

 Breaking News
  • No posts were found

Irritable Bowel Syndrome Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working

September 16
13:18 2021
Irritable Bowel Syndrome Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working
DelveInsight Business Research LLP
DelveInsight’s “Irritable Bowel Syndrome (IBS) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Irritable Bowel Syndrome (IBS), historical and forecasted epidemiology as well as the Irritable Bowel Syndrome (IBS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight has launched a new report on “Irritable Bowel Syndrome – Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’s “Irritable Bowel Syndrome – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Irritable Bowel Syndrome, historical and forecasted epidemiology as well as the Irritable Bowel Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Irritable Bowel Syndrome Market Report:

  1. Irritable bowel syndrome can be a very disabling syndrome for patients, and it has been shown to be a very common reason for seeking medical attention. Nearly 12% of patients seek medical care in primary care practices for Irritable Bowel Syndrome-related complaints. Studies have demonstrated that the prevalence of Irritable Bowel Syndrome ranges between 10-15%, however, the majority of these patients do not seek medical care. 

  2. According to Oka et al., 2020, the systematic review and meta-analysis showed a  global prevalence of  Irritable Bowel Syndrome of  9·2%  when the  Rome III criteria were used, and 3·8% with the Rome IV criteria.  Irritable Bowel Syndrome prevalence varied,  considerably in some instances, according to country, whether diagnostic criteria were applied strictly or approximated,  and the method used to collect symptom data in individual studies.

Key benefits of the report:

  1. Irritable Bowel Syndrome market report covers a descriptive overview and comprehensive insight of the Irritable Bowel Syndrome Epidemiology and Irritable Bowel Syndrome  market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

  2. The Irritable Bowel Syndrome market report provides insights on the current and emerging therapies.

  3. Irritable Bowel Syndrome market report provides a global historical and forecasted market covering drug outreach in 7MM.

  4. The Irritable Bowel Syndrome market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Irritable Bowel Syndrome market.

Got queries? Click here to know more about the Irritable Bowel Syndrome Market Landscape.

Irritable Bowel Syndrome Overview

Irritable bowel syndrome (Irritable Bowel Syndrome) is one of the most commonly diagnosed gastrointestinal diseases. Irritable Bowel Syndrome, in the absence of any other causative disease, is defined as the presence of abdominal pain or discomfort with altered bowel habits. The etiology of Irritable bowel syndrome (Irritable Bowel Syndrome) or Irritable Bowel Syndrome is broad and not clearly understood. However, the pathophysiology of Irritable Bowel Syndrome is broad and includes abnormalities involving motility, visceral sensation, brain-gut interaction, and psychosocial distress. Irritable Bowel Syndrome typically consists of abdominal pain or discomfort, altered bowel habits along with either constipation, diarrhea, or both. Other complaints in patients with Irritable Bowel Syndrome include bloating, distention, symptoms brought on my food intake, and a change in pain location, and stool pattern with time. 

Irritable Bowel Syndrome Market 

The dynamics of the Irritable Bowel Syndrome market is anticipated to change in the coming years owing to the expected launch of emerging therapies such as OrphoMed, Inc. 4D pharma and others during the forecasted period 2021-2030.

Learn more by requesting for sample @ Irritable Bowel Syndrome Market Landscape 

Irritable Bowel Syndrome Pipeline Therapies and Key Companies 

  • ORP-101: OrphoMed, Inc.

  • Blautix: 4D pharma

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Irritable Bowel Syndrome Patient Share (%) Overview at a Glance

5. Irritable Bowel Syndrome Market Overview at a Glance

6. Irritable Bowel Syndrome Disease Background and Overview

7. Irritable Bowel Syndrome Epidemiology and Patient Population

8. Country-Specific Patient Population of Irritable Bowel Syndrome 

9. Irritable Bowel Syndrome Current Treatment and Medical Practices

10. Unmet Needs

11. Irritable Bowel Syndrome Emerging Therapies

12. Irritable Bowel Syndrome Market Outlook

13. Country-Wise Irritable Bowel Syndrome Market Analysis (2017–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Irritable Bowel Syndrome Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Click here to read more about Irritable Bowel Syndrome Market Outlook 2030

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/